UTI Healthcare Fund-Direct Payout Inc Dist cum Cap Wdrl
UTI Healthcare Fund-Direct Payout Inc Dist cum Cap Wdrl

UTI Healthcare Fund-Direct Payout Inc Dist cum Cap Wdrl

Compare
Equity
Direct
Sector - Healthcare

NAV: ₹ 130.5 as on 30-11-2022

Fund Performance
zero opening, trading, fund transfer fee
9 people have invested ₹ 19.5K in mutual fund in the last three months

Fund Performance

Return
1M
3M
6M
1Y
3Y
5Y
This Fund
0.2%
4%
7.1%
-4.9%
23%
13.4%
Benchmark
2.6%
4.8%
13.2%
7.9%
17.6%
12%
Category
0.5%
4.7%
7.7%
-3.6%
23.3%
14.9%
About the Fund

UTI Healthcare Fund-Direct Payout Inc Dist cum Cap Wdrl is an equity fund. This fund was started on  1 January, 2013. The fund is managed by V Srivatsa, Kamal Gada. The fund could potentially beat inflation in the long-run.

Key parameters

1) UTI Healthcare Fund-Direct Payout Inc Dist cum Cap Wdrl has a NAV of 130.5135 as on 30-11-2022.

2) UTI Healthcare Fund-Direct Payout Inc Dist cum Cap Wdrl has 725 Cr worth of assets under management (AUM) as on 31-10-2022 and is less than category average.

3) The fund has an expense ratio 1.44 %.

Fund Overview

Expense ratio
Expense ratio
1.44%
Benchmark
Benchmark
S&P BSE Healthcare PR
AUM
AUM
₹725 Cr
Inception Date
Inception Date
1 January, 2013
Min Lumpsum/SIP
Min Lumpsum/SIP
₹5000/₹500
Exit Load
Exit Load
1%
Lock In
Lock In
No Lock-in
TurnOver
TurnOver
43.4%

Fund Distribution

  • Equity 98%
  • Debt & Cash 2%
Size breakup
Large cap
45.2%
Small cap
27.4%
Mid cap
25.4%

Sector Allocation

Oct'22

Sep'22

Aug'22

Health

98.5%

Basic Materials

1.5%

Top Holdings

  • All
  • Equity
  • Debt & Cash
Total Holdings33
Equity Holdings31
Debt Holdings2

What changed

in last one month
  • Scheme
  • Portfolio
AUM increased by 11.8 Cr in last 1M
Oct'22 return underperformed benchmark

Change in AUM

Oct'22
₹ 725.4 Cr
Sep'22
₹ 713.6 Cr
Aug'22
₹ 713.1 Cr

Fund Returns vs Benchmark

Oct'22
2.33%
5.37%
Sep'22
1.34%
-2.51%
Aug'22
0.66%
3.22%
Fund Return
Benchmark Return

Concentration Analysis

Fund
Oct'22
Oct'22
Aug'22
No of Holdings
33
33
33
Top 5 Company Concentration
39.8%
40%
38.9%
Company having highest exposure
Sun Pharmaceuticals Industries Ltd (13%)
Sun Pharmaceuticals Industries Ltd (12.3%)
Sun Pharmaceuticals Industries Ltd (11.4%)
No of Sectors
4
4
4
Top 5 Sectors Concentration
100%
100%
100%
Sector having highest exposure
Health (96.5%)
Health (97.1%)
Health (96.4%)

Fund Manager

V Srivatsa

V Srivatsa

Managing this fund since 3 March 2017

Top funds managed

Scheme
Annualised Returns(3Y)
Category Returns(3Y)
UTI Retirement Benefit Pension Fund- Direct
13.13%
--
UTI Hybrid Equity Fund-Growth - Direct
17.74%
14.89%
UTI Core Equity Fund-Growth Option - Direct
20.43%
18.35%
Kamal Gada

Kamal Gada

Managing this fund since 2 May 2022

Top funds managed

Scheme
Annualised Returns(3Y)
Category Returns(3Y)
UTI Healthcare Fund-Growth Option- Direct
23.01%
23.14%

AMC details

Address
PMS Division, UTI - Tower, “Gn” Block, Bandra Kurla Complex, Mumbai- 400051
Phone
+912266786666
Fund House
UTI Asset Management Co Ltd

Fund Highlights

meter
pointer

Very High Risk

Investors understand that their principal will be at Very High Risk
About the fund

About the fund

This fund has delivered an average annual returns of 13.61% since inception which is less than its category average return of 18.22%
Fund Allocations

Fund Allocations

This fund has an allocation of 98.01% in Equity, 0.17% in Debt and 1.81% in Cash related instruments
AUM size ₹725 Cr

AUM size ₹725 Cr

This fund has AUM of ₹725 Cr which is less than its category average of ₹ 1367 Cr
Expense Ratio 1.44%

Expense Ratio 1.44%

This fund has an expense ratio of 1.44% which is less than its category average expense ratio of 1.52%

Frequently Asked Questions

The current NAV of UTI Healthcare Fund-Direct Payout Inc Dist cum Cap Wdrl is 130.37.
Existing (Absolute + CAGR)
UTI Healthcare Fund-Direct Payout Inc Dist cum Cap Wdrl
Absolute Returns
CAGR Returns
1 Month Returns
1.07%
1.07%
6 Month Returns
7.11%
7.11%
1 Year Returns
-4.77%
-4.77%
3 Years Returns
85.92%
22.96%
5 Years Returns
86.63%
13.29%
With INDmoney, the process of investing is very simple and involves zero commission.
  • Click Buy on the fund name.
  • Input the amount you are looking to invest.
  • Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
  • Select your bank account and proceed with Payment.
1.44 as on November 2022
725 Cr as on November 2022
Sun Pharmaceuticals Industries Ltd(13.02%),Cipla Ltd(9.34%),Dr Reddy's Laboratories Ltd(7.27%),Apollo Hospitals Enterprise Ltd(5.83%),Fortis Healthcare Ltd(4.33%) as on November 2022
Health(96.54%),Cash Equivalent(1.81%),Basic Materials(1.48%) as on November 2022
The alpha ratio for the UTI Healthcare Fund-Direct Payout Inc Dist cum Cap Wdrl for various period is as follows:
Fund Name
Alpha 1 Year
Alpha 3 Years
Alpha 5 Years
UTI Healthcare Fund-Direct Payout Inc Dist cum Cap Wdrl
-1.5
2.45
2.2
As on month end.
The alpha for UTI Healthcare Fund-Direct Payout Inc Dist cum Cap Wdrl is calculated against S&P BSE Healthcare PR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.
The Beta ratio for the UTI Healthcare Fund-Direct Payout Inc Dist cum Cap Wdrl for various period is as follows:
Fund Name
Beta 1 Year
Beta 3 Years
Beta 5 Years
UTI Healthcare Fund-Direct Payout Inc Dist cum Cap Wdrl
0.94
0.93
0.9
As on month end.
The Beta for UTI Healthcare Fund-Direct Payout Inc Dist cum Cap Wdrl is calculated with S&P BSE Healthcare PR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.
The sharpe ratio for the UTI Healthcare Fund-Direct Payout Inc Dist cum Cap Wdrl for various period is as follows:
Fund Name
Sharpe Ratio 1 Year
Sharpe Ratio 3 Years
Sharpe Ratio 5 Years
UTI Healthcare Fund-Direct Payout Inc Dist cum Cap Wdrl
-0.55
0.95
0.49
As on month end.
The sharpe ratio for UTI Healthcare Fund-Direct Payout Inc Dist cum Cap Wdrl is calculated with S&P BSE Healthcare PR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.
The standard deviation for the UTI Healthcare Fund-Direct Payout Inc Dist cum Cap Wdrl for various period is as follows:
Fund Name
Standard Deviation 1 Year
Standard Deviation 3 Years
Standard Deviation 5 Years
UTI Healthcare Fund-Direct Payout Inc Dist cum Cap Wdrl
14.97
20.9
19.18
As on month end.
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.
2.13
0.42
V Srivatsa,Kamal Gada are the fund managers of UTI Healthcare Fund-Direct Payout Inc Dist cum Cap Wdrl
The Exit load of UTI Healthcare Fund-Direct Payout Inc Dist cum Cap Wdrl is 1%

Mutual Fund execution provided by

Technology facilitation Services provided by Finzoom Investment Advisors Pvt. Ltd. - Advisory unit. SEBI Registered Investment Advisor: INA100012190 | BASL Registration No. 1154 | BSE StarMF Platform code: 24801

Disclaimer: Mutual Fund investments are subject to market risks, read all scheme related documents carefully. Past performance is not indicative of future returns.